Osvaldo Augusto Sant'ANna

Osvaldo Augusto Sant'ANna

Auto-generated profile, based on publicly available information

Osvaldo Augusto Sant'ANna

Immunochemistry Laboratory, Instituto Butantan, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2008 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
IKIrina Kerkis
Irina Kerkis
CACarlos Eduardo Ambrosio
Carlos Eduardo Ambrosio
AKAlexandre Kerkis
Alexandre Kerkis
DMDaniele dos Santos Martins
Daniele dos Santos Martins
EZEder Zucconi
Eder Zucconi
MZMAYANA ZATZ
MAYANA ZATZ
Background: The golden retriever muscular dystrophy (GRMD) dogs represent the best available animal model for therapeutic trials aiming at the future treatment of human Duchenne muscular dystrophy (DMD). We have obtained a rare litter of six GRMD dogs (3 males and 3 females) born from an affected male and a carrier female which were submitted to a therapeutic trial with adult human stem cells to investigate their capacity to engraft into dogs muscles by local as compared to systemic injection without any immunosuppression.Methods: Human Immature Dental Pulp Stem Cells (hIDPSC) were transplanted into 4 littermate dogs aged 28 to 40 days by either arterial or muscular injections. Two non-injected dogs were kept as controls. Clinical translation effects were analyzed since immune reactions by blood exams and physical scores capacity of each dog. Samples from biopsies were checked by immunohistochemistry (dystrophin markers) and FISH for human probes.Results and Discussion: We analyzed the cells' ability in respect to migrate, engraftment, and myogenic potential, and the expression of human dystrophin in affected muscles. Additionally, the efficiency of single and consecutive early transplantation was compared. Chimeric muscle fibers were detected by immunofluorescence and fluorescentin situhybridisation (FISH) using human antibodies and X and Y DNA probes. No signs of immune rejection were observed and these results suggested that hIDPSC cell transplantation may be done without immunosuppression. We showed that hIDPSC presented significant engraftment in GRMD dog muscles, although human dystrophin expression was modest and limited to several muscle fibers. Better clinical condition was also observed in the dog, which received monthly arterial injections and is still clinically stable at 25 months of age.Conclusion: Our data suggested that systemic multiple deliveries seemed more effective than local injections. These findings open important avenues for further researches.

1 November 2016 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
KSKarina Scaramuzzi
Karina Scaramuzzi
GTGabriela D. Tanaka
Gabriela D. Tanaka
FNFrancisco Mariano Neto
Francisco Mariano Neto
PGPaulo R.A.F. Garcia
Paulo R.A.F. Garcia
JGJoel J.M. Gabrili
Joel J.M. Gabrili
OSOsvaldo A. Sant’anna
Osvaldo A. Sant’anna

15 March 2005 in Toxicon
Verified
Journal Article
Closed access
MSM.A. Stephano
M.A. Stephano
RGR. Guidolin
R. Guidolin
HHH.G. Higashi
H.G. Higashi
DTDenise Vilarinho Tambourgi
Denise Vilarinho Tambourgi
OSO.A. Sant'Anna
O.A. Sant'Anna

20 November 2019 in Toxins
Verified
Journal Article
Open access
PDF file
MSMorena Brazil Sant'Anna
Morena Brazil Sant'Anna
FLFlavia Souza Ribeiro Lopes
Flavia Souza Ribeiro Lopes
LKLouise Faggionato Kimura
Louise Faggionato Kimura
AGAline Carolina Giardini
Aline Carolina Giardini
OSOsvaldo Augusto Sant’anna
Osvaldo Augusto Sant’anna
GPGisele Picolo
Gisele Picolo
Neuropathic pain is a disease caused by structural and functional plasticity in central and peripheral sensory pathways that produce alterations in nociceptive processing. Currently, pharmacological treatment for this condition remains a challenge. Crotoxin (CTX), the main neurotoxin of Crotalus durissus terrificus rattlesnake venom, has well described prolonged anti-inflammatory and antinociceptive activities. In spite of its potential benefits, the toxicity of CTX remains a limiting factor for its use. SBA-15 is an inert nanostructured mesoporous silica that, when used as a vehicle, may reduce toxicity and potentiate the activity of different compounds. Based on this, we propose to conjugate crotoxin with SBA-15 (CTX:SBA-15) in order to investigate if when adsorbed to silica, CTX would have its toxicity reduced and its analgesic effect enhanced in neuropathic pain induced by the partial sciatic nerve ligation (PSNL) model. SBA-15 enabled an increase of 35% of CTX dosage. Treatment with CTX:SBA-15 induced a long-lasting reduction of mechanical hypernociception, without modifying the previously known pathways involved in antinociception. Moreover, CTX:SBA-15 reduced IL-6 and increased IL-10 levels in the spinal cord. Surprisingly, the antinociceptive effect of CTX:SBA-15 was also observed after oral administration. These data indicate the potential use of the CTX:SBA-15 complex for neuropathic pain control and corroborates the protective potential of SBA-15.

1 December 2011 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
KSKarina Scaramuzzi
Karina Scaramuzzi
DODenise Cristina André Oliveira
Denise Cristina André Oliveira
LCLuciana Vieira Carvalho
Luciana Vieira Carvalho
DTDenise Vilarinho Tambourgi
Denise Vilarinho Tambourgi
ETElisabeth Christina Nunes Tenório
Elisabeth Christina Nunes Tenório
OSOsvaldo Augusto Sant´anna
Osvaldo Augusto Sant´anna
Objective: To evaluate the applicability of SBA-15 silica as an adjuvant in immunizations with purified particles of the viral protein HBsAg, the main component of hepatitis B vaccine, Butang®, produced by Instituto Butantan. Methods: BALB/c mice orally or subcutaneously received 0.5 μg of HBsAg adsorbed/encapsulated to SBA-15 or adsorbed to Al(OH)3. To assess the secondary immune response, a subcutaneous booster was administered 30 days after the first immunization. Individual serum and fecal samples of each group were periodically collected for specific antibody titration by ELISA. Results: Analysis of secretory IgA showed that mice orally primed with HBsAg on SBA-15 had increased levels of specific antibodies in primary and secondary immune responses. Specific serum IgA and IgG titers in HBsAg:SBA-15-orally immunized mice reached higher levels after the booster, demonstrating the effectiveness of oral vaccination with the use of silica. All immunized groups showed higher IgG1 levels. Conclusion: Our results clearly indicate the promising use of SBA-15 as an adjuvant, especially in oral immunizations.

19 November 2009 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EMEliana B. Marengo
Eliana B. Marengo
ACAlessandra Gonçalves Commodaro
Alessandra Gonçalves Commodaro
JPJean Pierre S. Peron
Jean Pierre S. Peron
LMLuciana V. de Moraes
Luciana V. de Moraes
FPFernanda C. V. Portaro
Fernanda C. V. Portaro
OSOsvaldo Augusto Sant'ANna
Osvaldo Augusto Sant'ANna
The 60kDa heat shock protein family, Hsp60, constitutes an abundant and highly conserved class of molecules that are highly expressed in chronic-inflammatory and autoimmune processes. Experimental autoimmune uveitis [EAU] is a T cell mediated intraocular inflammatory disease that resembles human uveitis. Mycobacterial and homologous Hsp60 peptides induces uveitis in rats, however their participation in aggravating the disease is poorly known. We here evaluate the effects of the Mycobacterium leprae Hsp65 in the development/progression of EAU and the autoimmune response against the eye through the induction of the endogenous disequilibrium by enhancing the entropy of the immunobiological system with the addition of homologous Hsp. B10.RIII mice were immunized subcutaneously with interphotoreceptor retinoid-binding protein [IRBP], followed by intraperitoneally inoculation of M. leprae recombinant Hsp65 [rHsp65]. We evaluated the proliferative response, cytokine production and the percentage of CD4+IL-17+, CD4+IFN-γ+ and CD4+Foxp3+ cells ex vivo, by flow cytometry. Disease severity was determined by eye histological examination and serum levels of anti-IRBP and anti-Hsp60/65 measured by ELISA. EAU scores increased in the Hsp65 group and were associated with an expansion of CD4+IFN-γ+ and CD4+IL-17+ T cells, corroborating with higher levels of IFN-γ. Our data indicate that rHsp65 is one of the managers with a significant impact over the immune response during autoimmunity, skewing it to a pathogenic state, promoting both Th1 and Th17 commitment. It seems comprehensible that the specificity and primary function of Hsp60 molecules can be considered as a potential pathogenic factor acting as a whistleblower announcing chronic-inflammatory diseases progression.